Skip to main content
. 2018 Feb 2;3(3):652–660. doi: 10.1016/j.ekir.2018.01.008

Table 1.

Patient characteristics

Sex, male/female, n 59/14
Race, Caucasian, % 99
Age, yr, at ESRD, median (min−max) 26 (11−71)
Time on dialysis, mo median (min−max) 33 (1−190)
Deafness (n) 48
 Age, yr, at hearing aid, median (min−max) 24 (6−55)
Age, years, at first TP, median (min−max) 28 (12−73)
Duration of post-TP follow-up, yr, median (min−max) 16 (1−42)
Living/deceased donor (n) 13/80
Number of TPs, n 93
 Second/third TP 16/2
Immunosuppressive regimen, %
 Induction 100
 Cyclosporine 69
 Tacrolimus 31
 Mycophenolate mofetil 25
 Azathioprine 73
 Sirolimus 1
 Corticosteroids 98

ESRD, end-stage renal disease; min−max, minimum−maximum; TP, transplantation.